
CHD Stock Forecast & Price Target
CHD Analyst Ratings
Bulls say
Church & Dwight Co. is poised for continued growth, with its international business expected to expand 7-8% this year, and a projected organic sales growth of 3-4% for 2025, primarily fueled by increased volume. The company's recent performance highlights a 2.7% organic growth in Consumer Domestic, supported by personal care sales, while Consumer International saw a notable increase of 9.6%, bolstered by both volume and price/mix improvements. Additionally, management anticipates a gross margin expansion of approximately 25 basis points, driven by favorable product mix, volume growth, and enhanced productivity, positioning the company for improved profitability despite rising input costs.
Bears say
Church & Dwight Co. experiences substantial challenges within its Vitamin, Mineral, and Supplement (VMS) segment, as evidenced by a significant 16% sales decline for its Vitafusion brand compared to just 2.3% growth in the overall gummy vitamin category. Financial estimates for FY25 have been revised downward, with projected organic sales growth of only 3.3%, reflecting a decrease in marketing expenses and general selling and administrative costs. The company’s guidance for Q1 2025 indicates a subdued organic sales growth expectation of 2.0%, which falls short of projections and highlights concerns regarding the adverse economic conditions likely impacting consumer demand.
This aggregate rating is based on analysts' research of Church & Dwight and is not a guaranteed prediction by Public.com or investment advice.
CHD Analyst Forecast & Price Prediction
Start investing in CHD
Order type
Buy in
Order amount
Est. shares
0 shares